Tirzepatide
A dual GIP/GLP-1 receptor agonist developed by Eli Lilly, FDA-approved for type 2 diabetes and demonstrating weight reductions of up to 22.5% in clinical trials. All presented information is based on scientific publications which can be found at the end of product description below.
Product Specifications
Description
All presented information is based on scientific publications which can be found at the end of product description below.
Tirzepatide is a 39-amino-acid dual agonist of GIP and GLP-1 receptors. Marketed as Mounjaro (diabetes) and Zepbound (obesity), it is the first approved dual incretin receptor agonist.
Research Highlights
1. Type 2 Diabetes โ SURPASS trials showed HbA1c reductions of ~2.4% at 15mg, with substantial target achievement below 5.7%.
2. Weight Management โ SURMOUNT trials demonstrated up to 22.5% weight loss over 72 weeks, approaching bariatric surgery outcomes.
3. Dual Incretin Mechanism โ GIP complements GLP-1 by enhancing adipose insulin sensitivity and fat mobilization.
4. Cardiovascular โ Beneficial effects on blood pressure, lipids, and inflammatory markers.
5. Hepatic Benefits โ Significant liver fat reduction and improved hepatic inflammation markers.
6. Pharmacokinetics โ Once-weekly dosing via C20 fatty diacid albumin binding.
References available upon request.
The product is intended for scientific research and development purposes only. Chemical substances shall not be used as a drug, medicine, active substance, medical aid, cosmetic product, a substance for production of a cosmetic product neither for human consumption that is any food or food supplement or otherwise similarly used on humans or animals. Intended only for in-vitro research, such as Receptor-ligand binding studies, Enzyme activity assays, Cell proliferation assays, Cell signaling assays, Epitope mapping, etc.
Research Use Only: The product is intended for scientific research and development purposes only. Chemical substances shall not be used as a drug, medicine, active substance, medical aid, cosmetic product, a substance for production of a cosmetic product neither for human consumption that is any food or food supplement or otherwise similarly used on humans or animals. Intended only for in-vitro research, such as Receptor-ligand binding studies, Enzyme activity assays, Cell proliferation assays, Cell signaling assays, Epitope mapping, etc.
๐ช๐บ EU & UK Shipped โข Free over โฌ300 โข 2-5 Business Days
Frequently asked questions
- Each batch is HPLC-MS verified at โฅ99% purity. A Certificate of Analysis (COA) including HPLC chromatograms and mass spectrometry data is provided with every shipment.
- Store the lyophilised vial at -20ยฐC, protected from light. Once reconstituted for in-vitro work, follow your laboratory's standard handling and stability protocols. Most reconstituted peptides remain stable at 2-8ยฐC for short-term use.
- No. All Peptra Labs peptides are supplied strictly for laboratory and educational research use only. They are not approved for human or veterinary administration, are not evaluated by the FDA or EMA, and must not be used as drugs, supplements, or cosmetic products.
- We ship across the EU and the United Kingdom. Most orders arrive within 2-5 business days. Free shipping on orders over โฌ300.
- Every order includes the product, a Certificate of Analysis (HPLC + MS data, lot number, synthesis date, storage recommendations), and an invoice. Research-use disclaimers are stated on both packaging and documentation.
- Yes. Recent lab reports are available in our Lab Reports section. If you'd like the COA for a specific lot before purchasing, contact us at info@peptralabs.com.
